There are 2867 resources available
Welcome and Introduction
Presenter: Nick Turner
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
Welcome and introduction
Presenter: Giuseppe Curigliano
Session: ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives
Resources:
Webcast
Welcome and introduction
Presenter: Paolo Ascierto
Session: Bristol Myers Squibb - The Evolving Treatment Landscape for Metastatic Melanoma: A Clinical Lens on Current Decision Making
Resources:
Webcast
Welcome and Introduction
Presenter: Diana Lüftner
Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases
Resources:
Webcast
The conflict in Ukraine and its effect on healthcare inequalities in Europe
Presenter: Richard Sullivan
Session: Supporting Ukraine: The European cancer advocacy community responds
Resources:
Slides
Webcast
What are oral SERDs and why do our patients need them?
Presenter: Komal Jhaveri
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
Developments in the treatment algorithm of patients with metastatic HER2-amplified/overexpressing breast cancer
Presenter: Javier Cortés
Session: ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives
Resources:
Webcast
Emerging Data for the First-line Treatment of Metastatic Melanoma
Presenter: Nicolas Meyer
Session: Bristol Myers Squibb - The Evolving Treatment Landscape for Metastatic Melanoma: A Clinical Lens on Current Decision Making
Resources:
Webcast
The HER2+ breast cancer pathway
Presenter: Icro Meattini
Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases
Resources:
Webcast
My story
Presenter: Nataliia Hrad
Session: Supporting Ukraine: The European cancer advocacy community responds
Resources:
Slides
Webcast